Amed Ventures
Venture capitalLewes · 1 people tracked
Find your way into Amed Ventures
Fund manager profile
Amed Ventures is a venture fund manager based in Lewes. SEC filings show 1 venture fund on record, most recently Amed Ventures I, L.P. ($22M offering) filed July 2020.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 1 people
from public directoriesWhat they invest in
from 10 of 11 portfolio companiesHealthtech ×7Medical Devices ×7Biotech ×3Hardware ×3Advanced Manufacturing ×1AI & Machine Learning ×1Digital Health ×1Enterprise Software ×1
HQs:United States×11
Investments · 11 tracked
founders shown can be your intro pathBy year:2025 · 12023 · 32021 · 32020 · 18 dated
Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients.
HardwareHealthtechMedical DevicesCampbell, US
Co-investorsThe Capital PartnershipDelos Capital
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.
HardwareHealthtechMedical DevicesCampbell, US
Nitin Salunke(President & CEO)inJean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)
BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)
Co-investors415 CapitalThe Capital PartnershipNovo HoldingsUnorthodox Ventures
Verge Medical (formerly Ostial Corporation) develops medical devices for aorto-ostial vascular interventions, including the FLASH Flex aorto-ostial angioplasty system and the RoVo mechanical thrombectomy device, used by physicians for coronary and peripheral vascular cases.
HealthtechMedical Devices
Mike Buck(Chief Executive Officer)inAdam Tschida(General Manager & COO)in
Co-investorsDelos Capital
ProtoLase provides laser processing services for organizations requiring clinical relevance and product efficiency in their manufacturing or product development processes.
Advanced ManufacturingHardwareMedical DevicesMaple Grove, US
DARLENE KIEFER(Chief Financial Officer of Issuer)inBRADY HATCHER(Director and Chief Operating Officer of Issuer)inDARYL KIEFER(Director and Chief Executive Officer of Issuer)in
Board seatYuan Wei Tai· per SEC Form D · $3.3M raise · filed Dec 2021
Chronus is a platform that connects employees for guided, AI-assisted conversations focused on career development, mentoring, community building, and change adoption in enterprise organizations.
AI & Machine LearningEnterprise SoftwareFuture of WorkHR TechSaaSNew York, US
Aaron Hurst(Founder)in
Co-investorsVoyager CapitalAlly Bridge GroupAscension VenturesBain Capital Life SciencesCatalio Capital ManagementDelos Capital+2 more
Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness.
BiotechDigital HealthHealthtechMedical DevicesVan Nuys, US
Eric Leuthardt(Director)inLeo Petrossian(Executive Officer, Director)in
BoardYuanwei Tai(Director)Kevin Reilly(Director)inFred Khosravi(Director)inStavros Vizirgianakis(Director)
Co-investorsAlly Bridge Group
Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.
BiotechFemTechHealthtechMedical DevicesBedford, US
AMARPREET SAWHNEY(Executive Officer, Director, Promoter)inAmar Sawhney(Founder)inNICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)
BoardTARA BUTLER(Executive Officer, Director, Promoter)
Co-investorsAscension VenturesClavystBioDelos CapitalFemHealth VenturesIyengar Capital PartnersCatalyst Health Ventures
Sealonix develops hemostatic sealants based on proprietary biomaterials to control surgical bleeding, targeting surgeons and patients undergoing abdominopelvic and other surgical procedures.
BiotechMedical DevicesNew MaterialsBedford, US
Amarpreet Sawhney(Executive Officer, Director)Amar Sawhney(Founder)
Co-investorsExcelestar VenturesJ2 Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesRejoni · femtechinsider.com · Jul 1, 2026
Akura Medical · medtechdive.com · Dec 3, 2025
Neurolutions · fiercebiotech.com · Apr 8, 2025
Frequently asked questions
- How many investments has Amed Ventures made?
- Amed Ventures has 11 tracked investments, including 1 dated in the last 24 months.
- Where is Amed Ventures located?
- Amed Ventures is headquartered in Lewes, US.